Stockholders’ Equity and Redeemable Preferred Stock (Details) - USD ($)				1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 15, 2021	Feb. 02, 2021	May 01, 2017	Sep. 15, 2021	Jun. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Dec. 31, 2021	Aug. 13, 2021
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Reverse stock split, description	the Company announced that its shareholders had approved a reverse split of its common stock and Series C Redeemable Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Redeemable Preferred Stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders.
Common stock shares outstanding					9,608,937		9,608,937	9,163,039
Common stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Gross proceeds (in Dollars)				$ 12,500,000
Investment (in Dollars)									$ 4,000,000
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Voting rights, description							One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.
Maximum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock shares outstanding	88,300,000
Minimum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock shares outstanding	8,800,000
Series C Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding					200		200	200
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Series C Preferred Stock [Member] | Maximum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding	2,000
Series C Preferred Stock [Member] | Minimum [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding	200
Series F Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preference stock shares outstanding					173,333		173,333	173,333
Preferred stock, par value (in Dollars per share)					$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock dividends (in Dollars)					$ 13,144		$ 26,145
Series C Redeemable Preferred Stock [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Preferred stock dividends (in Dollars)					$ 75,000		$ 150,000
Cumulative dividends rate			15.00%
September 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Aggregate of sale, shares				2,788,750
Common stock, par value (in Dollars per share)				$ 0.0001
Aggregate of purchase shares				2,788,750
Exercise price per share (in Dollars per share)				$ 4.95
Additional shares of common stock				363,750
Warrant exercise price (in Dollars per share)	$ 3.956
August 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock, par value (in Dollars per share)									$ 0.0001
Shares issued									1,333,333
Preferred stock, par value (in Dollars per share)									$ 0.0001
Common stock, shares issued						656,604			666,667
Common stock exercise price per share (in Dollars per share)									$ 7.8
Preferred stock, shares issued						1,160,000
Warrants per share (in Dollars per share)	$ 4.95
February 2021 Offering [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Registered direct offering, description		(i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.
January 2021 Warrant exchange [Member]
Stockholders’ Equity and Redeemable Preferred Stock (Details) [Line Items]
Common stock, shares issued					246,913		246,913
Common stock exercise price per share (in Dollars per share)					$ 15.25		$ 15.25
Original warrants							50,000
Addition of warrants							50,000